Stock market today: Dow, S&P 500, Nasdaq rise as AI worries recede, with Fed minutes ahead
Oil prices rose on Wednesday as traders priced in continued geopolitical risk and stringent sanctions after peace talks between Russia and Ukraine appeared to collapse after only two hours.
Futures on Brent crude (BZ=F), the international pricing benchmark, rose over 2% to trade around $69,
Read MoreNvidia leads the US stock market higher
NEW YORK (AP) — The U.S. stock market is rising on Wednesday, led by its most influential stock, Nvidia.
The S&P 500 climbed 0.6% and pulled within 1.4% of its all-time high set late last month. The Dow Jones Industrial Average was up 222 points, or 0.5%, as of 10 a.m.
» Read more about: Nvidia leads the US stock market higher »
Read MoreNew ETFs Will Now Let You Bet on Who Wins the White House in 2028
© FAMILY STOCK / Shutterstock.com
Wall Street is about to let you put your money where your political predictions are. Roundhill Investments has filed prospectuses for ETFs tied directly to prediction markets on who wins the 2028 presidential election, plus the House and Senate. It’s a groundbreaking development that blurs the line between investing and political betting.
» Read more about: New ETFs Will Now Let You Bet on Who Wins the White House in 2028 »
Read MoreStock market today: Dow, S&P 500, Nasdaq futures rise as AI worries recede, with Fed minutes ahead
Oil prices rose on Wednesday as traders priced in continued geopolitical risk and stringent sanctions after peace talks between Russia and Ukraine appeared to collapse after only two hours.
Futures on Brent crude (BZ=F), the international pricing benchmark, rose over 2% to trade around $69,
Read MoreThe Burst
1 Under-the-Radar Pharma Stock with 90% Upside?
Billionaire Stanley Druckenmiller has been making large changes to his portfolio recently, leaving retail investors struggling to keep up with what the famous stock picker is thinking.
One of the smaller holdings in Druckenmiller’s portfolio that makes for interesting examination is ARS Pharmaceuticals (NASDAQ:SPRY).
Druckenmiller’s 536,900 shares of SPRY are currently valued at around $7 million.
» Read more about: 1 Under-the-Radar Pharma Stock with 90% Upside? »
Read MoreThe Ivy
Will This Tiny Quantum Stock 2x by 2030?
IonQ isn’t a household name yet. But give it time. This small-cap quantum computing company is pulling in some big-league attention and the numbers from early 2025 are starting to back it up.
You’re probably used to hearing about quantum computing like it’s some distant dream but in Q1 2025, that revenue hit $7.6 million.
» Read more about: Will This Tiny Quantum Stock 2x by 2030? »
Read MoreThe Spotlight
Time To Buy This Magnificent 7 Stock?
Usually investing is about spotting a stock that is underpriced relative to fair value. Trading is about finding a stock that meets some chart criterion. Maybe it’s a breakout, a cup-and-handle, a doji, or some buy signal or other. Whatever the approach, the focus is on a single position.
But sometimes, comparative analysis highlights opportunities that otherwise might fall under the radar.